COVID-19 vaccine, Novavax, to be available to Australians aged 18 years and over
27 January 2022
Novavax COVID-19 vaccine, also known as Nuvaxovid (Biocelect Pty Ltd/Novavax Inc) has been provisionally approved by the Therapeutic Goods Administration (TGA) for use in a primary course of vaccination in people aged 18 years and older. The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the Novavax vaccine be given in two doses, at […]
Continue Reading